About us


Science&Care is committed to making a positive contribution to pandemic response. Our rapid tests provide a solution for systematic screening of asymptomatic and symptomatic virus carriers as well as for rapid and uncomplicated near-patient laboratory diagnosis of any immune response to an infection that has taken place or after vaccination.

Quality of our products

Unibioscience Antigen Rapid Test

To verify our quality, we commissioned a laboratory in America to perform a series of tests on a total of 192 samples to check our sensitivity and specificity. Since we, like many scientists, consider screening to be a fundamental part of a strategy against the spread of the pandemic, further series of tests were arranged. We contracted a nationally accredited laboratory to test a total of 1720 samples from both symptomatic and asymptomatic Covid-19 positive subjects and then correlate these results with the Ct value of the polymerase chain reaction (PCR) assay.

If we take the current WHO position paper as a basis (see below for link of literature), we succeed in identifying infectious people. It proves that we are able to contribute to stopping chains of infection by identifying not only symptomatic infected people but also asymptomatic infected people from a given population.

Bildschirmfoto 2020-10-19 um 20.17.39

Unibioscience Antibody Rapid Test

To verify the quality of the rapid antibody test, whole blood samples from a total of 246 subjects immunoreactive in ELISA diagnostics with detected IgG and IgM antibodies were tested with the Unibioscience antibody test in a state-accredited laboratory. The mean optical density (OD) of the ELISA method for the detection of antibodies in whole blood was 26.43 OD (min. 13.20-max. 40.80) for IgG and 18.11 OD (min. 12.00-max. 26.50) for IgM. Our results, especially with regard to the optimal time of antibody detectability after symptom onset, are in agreement with validation results from other reputable manufacturers. 1

1. Prazuck T, Colin M, Giachè S, Gubavu C, Seve A, Rzepecki V, Chevereau-Choquet M, Kiani C, Rodot V, Lionnet E, Courtellemont L, Guinard J, Pialoux G, Hocqueloux L. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip. PLoS One. 2020 Sep 17;15(9):e0237694. doi: 10.1371/journal.pone.0237694. PMID: 32941461; PMCID: PMC7498027.

FFP2 masks

In the context of the COVID-19 pandemic, the wearing of a face mask has become common and ubiquitous, both in hospitals and in the community. Our FFP2 mask has undergone a successful verification procedure (conformity assessment procedure) and accordingly has a CE mark. The filtering performance of the mask material has been tested against the European standard EN 149:2001+A1:2009 with aerosols.